PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2007 - Veterinary Compounding
View All Articles in Issue

Page(s): 438-439

PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Page 1

PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Page 2

Download in electronic PDF format for $65

Abstract:

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, US Food and Drug Administration, FDA, unapproved drugs, Compliance Policy Guide

Related Categories: LEGAL, ADVERSE DRUG EVENTS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Allen Loyd V Jr	Jul/Aug 2007 Pg. 350-351
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Allen Loyd V Jr	Sep/Oct 2007 Pg. 438-439
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D	Jan/Feb 2005 Pg. 44-46
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions